Jack Bartram

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.

A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.

Journal: Science translational medicine
Published: August 19, 2026

A Rare Case of FANCC-Mutated Fanconi Anaemia Presenting With a Negative Chromosome Breakage Test.

A Rare Case of FANCC-Mutated Fanconi Anaemia Presenting With a Negative Chromosome Breakage Test.

Journal: Pediatric blood & cancer
Published: January 23, 2026

Single-cell transcriptional consequences of leukaemogenic SETBP1 mutations.

Single-cell transcriptional consequences of leukaemogenic SETBP1 mutations.

Journal: British journal of haematology
Published: October 17, 2025

MCL1 inhibition to enhance the efficacy of MYB targeting in pediatric acute myeloid leukemia.

MCL1 inhibition to enhance the efficacy of MYB targeting in pediatric acute myeloid leukemia.

Journal: Cell death & disease
Published: August 22, 2025

B-Cell Acute Lymphoblastic Leukaemia Presenting With Bilateral Renal Enlargement.

B-Cell Acute Lymphoblastic Leukaemia Presenting With Bilateral Renal Enlargement.

Journal: Cureus
Published: August 21, 2025

Late Onset Blinatumomab-Related Neurotoxicity in a Child With B-Cell Acute Lymphoblastic Leukemia.

Late Onset Blinatumomab-Related Neurotoxicity in a Child With B-Cell Acute Lymphoblastic Leukemia.

Journal: Pediatric blood & cancer
Published: June 03, 2025

A non-canonical lymphoblast in refractory childhood T-cell leukaemia.

A non-canonical lymphoblast in refractory childhood T-cell leukaemia.

Journal: Nature communications
Published: April 27, 2025

Single cell transcriptional evolution of myeloid leukemia of Down syndrome.

Single cell transcriptional evolution of myeloid leukemia of Down syndrome.

Journal: Nature communications
Published: April 13, 2025

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Journal: Blood
Published: March 21, 2025

Update on long-term outcomes of a cohort of patients with TCF3::HLF-positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation.

Update on long-term outcomes of a cohort of patients with TCF3::HLF-positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation.

Journal: Haematologica
Published: November 09, 2024

PROM1/CD133 marks a proliferative stem cell-like population of blasts in KMT2A rearranged infant ALL.

PROM1/CD133 marks a proliferative stem cell-like population of blasts in KMT2A rearranged infant ALL.

Journal: Blood advances
Published: October 29, 2024

Real-world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies.

Real-world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies.

Journal: British journal of haematology
Published: August 05, 2024
Showing 1-12 of 64

Last Updated: 09/26/2026